Biotransformation of trans-4,5-Dihydroxy-4,5-dihydrobenzo[a]pyrene to Benzo[a]pyrene Bis-Diols and DNA Adducts by Induced Rat Liver Microsomes
- 5 October 2000
- journal article
- research article
- Published by American Chemical Society (ACS) in Chemical Research in Toxicology
- Vol. 13 (11) , 1125-1134
- https://doi.org/10.1021/tx000111b
Abstract
The biotransformation of (+/-)-trans-4,5-dihydroxy-4, 5-dihydrobenzo[a]pyrene (trans-B[a]P-4,5-diol), the K-region dihydrodiol of B[a]P, by beta-naphthoflavone (BNF)-induced rat liver microsomes was studied. trans-B[a]P-4,5-diol was metabolized to six major products as characterized by NMR, MS, and UV spectroscopy, and all were identified as bis-diols: two diastereomers of trans,trans-4, 5:7,8-tetrahydroxy-4,5:7,8-tetrahydrobenzo[a]pyrene (trans, trans-B[a]P-4,5:7,8-bis-diol), two diastereomers of trans,trans-4, 5:9,10-tetrahydroxy-4,5:9,10-tetrahydrobenzo[a]pyrene (trans, trans-B[a]P-4,5:9,10-bis-diol), and two diastereomers of the somewhat unusual trans,trans-1,2:4,5-tetrahydroxy-1,2:4, 5-tetrahydrobenzo[a]pyrene (trans,trans-B[a]P-1,2:4,5-bis-diol). BNF-induced rat liver microsomes also metabolized B[a]P to the same trans-B[a]P-4,5-diol-derived bis-diols. The ability of trans-B[a]P-4, 5-diol to form DNA adducts was investigated using (32)P-postlabeling techniques specifically designed to detect stable polar DNA adducts. Four DNA adducts were detected after microsomal activation of trans-B[a]P-4,5-diol with calf thymus DNA. Further analyses indicated that each of these stable polar DNA adducts was derived from the further metabolic activation of the trans,trans-B[a]P-4,5:7, 8-bis-diols. We conclude that trans-B[a]P-4,5-diol can be metabolized to a series of B[a]P-bis-diols, and can also be metabolically activated to form stable polar DNA adducts. The trans, trans-B[a]P-4,5:7,8-bis-diols were shown to be metabolic intermediates in the formation of these DNA adducts.Keywords
This publication has 9 references indexed in Scilit:
- 8,9-Dihydroxy-8,9-dihydrodibenzo[ a , l ]pyrene is a potent morphological cell-transforming agent in C3H10T 1 / 2 Cl8 mouse embryo fibroblasts in the absence of detectable stable covalent DNA adductsCarcinogenesis: Integrative Cancer Research, 2000
- Analysis of Highly Polar DNA Adducts Formed in SENCAR Mouse Epidermis Following Topical Application of Dibenz[a,j]anthraceneChemical Research in Toxicology, 1998
- Metabolic Activation of Racemic and Enantiomeric trans-8,9-Dihydroxy-8,9-dihydrodibenzo[a,l]pyrene (Dibenzo[def,p]chrysene) to Dibenzo[a,l]pyrene-bis-dihydrodiols by Induced Rat Liver Microsomes and a Recombinant Human P450 1A1 System: The Role of the K-Region-Derived Metabolic Intermediates in the Formation of Dibenzo[a,l]pyrene−DNA AdductsChemical Research in Toxicology, 1998
- Induction of CYP isoenzymes in various organs of rats by 3-methylcholanthrene or β-naphthoflavoneCancer Letters, 1995
- Morphological transformation and DNA adduct formation by dibenz[a,h]anthracene and its metabolites in C3H10T1/2CL8 cellsCarcinogenesis: Integrative Cancer Research, 1994
- Bisdihydrodiols, rather than dihydrodiol oxides, are the principal microsomal metabolites of tumorigenic trans-3,4-dihydroxy-3,4-dihydrodibenz[a,h]anthraceneChemical Research in Toxicology, 1994
- The metabolism of pyrene by rat liver microsomes and the influence of various mono-oxygenase inducersXenobiotica, 1982
- Transformation of normal hamster cells by benzo(a)pyrene diol‐epoxideInternational Journal of Cancer, 1977
- Tumour-initiating activities on mouse skin of dihydrodiols derived from benzo[a]pyreneBritish Journal of Cancer, 1976